214 related articles for article (PubMed ID: 20013873)
1. Free leptin index and PAPP-A: a first trimester maternal serum screening test for pre-eclampsia.
Hedley PL; Placing S; Wøjdemann K; Carlsen AL; Shalmi AC; Sundberg K; Tabor A; Christiansen M
Prenat Diagn; 2010 Feb; 30(2):103-9. PubMed ID: 20013873
[TBL] [Abstract][Full Text] [Related]
2. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.
Poon LC; Maiz N; Valencia C; Plasencia W; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jan; 33(1):23-33. PubMed ID: 19090499
[TBL] [Abstract][Full Text] [Related]
3. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):7-10. PubMed ID: 18000943
[TBL] [Abstract][Full Text] [Related]
4. First trimester maternal serum pregnancy-specific beta-1-glycoprotein (SP1) as a marker of adverse pregnancy outcome.
Pihl K; Larsen T; Laursen I; Krebs L; Christiansen M
Prenat Diagn; 2009 Dec; 29(13):1256-61. PubMed ID: 19911417
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
6. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.
Akolekar R; Syngelaki A; Beta J; Kocylowski R; Nicolaides KH
Prenat Diagn; 2009 Dec; 29(12):1103-8. PubMed ID: 19777530
[TBL] [Abstract][Full Text] [Related]
8. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
[TBL] [Abstract][Full Text] [Related]
9. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
Spencer K; Bindra R; Cacho AM; Nicolaides KH
Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
[TBL] [Abstract][Full Text] [Related]
10. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester.
Leung TY; Sahota DS; Chan LW; Law LW; Fung TY; Leung TN; Lau TK
Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339
[TBL] [Abstract][Full Text] [Related]
11. Human placental lactogen is a first-trimester maternal serum marker of Down syndrome.
Christiansen M; Sørensen TL; Nørgaard-Pedersen B
Prenat Diagn; 2007 Jan; 27(1):1-5. PubMed ID: 17154235
[TBL] [Abstract][Full Text] [Related]
12. Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia.
De Villiers CP; Hedley PL; Placing S; Wøjdemann KR; Shalmi AC; Carlsen AL; Rode L; Sundberg K; Tabor A; Christiansen M
Clin Chem Lab Med; 2017 Nov; 56(1):65-74. PubMed ID: 28704180
[TBL] [Abstract][Full Text] [Related]
13. Serum leptin in first-trimester Down syndrome pregnancies.
Hedley P; Christiansen M
Prenat Diagn; 2008 Jun; 28(6):475-7. PubMed ID: 18437707
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
15. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.
Spencer K; Kagan KO; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):49-52. PubMed ID: 18186136
[TBL] [Abstract][Full Text] [Related]
16. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy.
Spencer K; Bindra R; Nicolaides KH
Prenat Diagn; 2003 Oct; 23(10):851-5. PubMed ID: 14558032
[TBL] [Abstract][Full Text] [Related]
17. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
18. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
[TBL] [Abstract][Full Text] [Related]
19. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
20. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
Palomaki GE; Wright DE; Summers AM; Neveux LM; Meier C; O'donnell A; Huang T; Knight GJ; Haddow JE
Prenat Diagn; 2006 Aug; 26(8):730-9. PubMed ID: 16810709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
